Anti-Saccharomyces Cerevisiae Antibodies
ASCA
Description
"Anti-Saccharomyces Cerevisiae Antibodies" (ASCA) test checks for antibodies that react to yeast in the gut and are often associated with Crohn’s disease. Elevated ASCA levels suggest immune system activity affecting the digestive tract. Doctors order this test when symptoms like abdominal pain, diarrhea, or weight loss appear, and need help distinguishing between inflammatory bowel diseases. Results support diagnosis and inform care plans tailored to digestive health. Monitoring ASCA over time can guide treatment response and long-term management.
Test Category
Antibodies
Procedure
Invasive
Sample Type
Blood – Serum
Units
Units Per Milliliter
Procedure Category
Blood Draw
Test Group
Chronic Illness Group, Autoimmune Condition Group
Test Group Description
Chronic Illness Group: This group encompasses a range of tests specifically tailored to assess markers associated with chronic health conditions, providing comprehensive insights into the management and monitoring of chronic illnesses. Autoimmune Condition Group: Tests within this group focus on markers associated with autoimmune diseases, providing insights into the body's immune response against its own tissues.
Optimal Range
For All Individuals:
Conventional Unit: < 20.00 U/mL
SI Unit: < 20.00 U/mL
Normal Range
For All Individuals:
Conventional Unit: < 20.00 U/mL
SI Unit: < 20.00 U/mL
Results That Differ From The Norm (Direct and Indirect Causes)
Increased levels may indicate:
Crohn's Disease (Chronic inflammatory bowel disease causing inflammation of the digestive tract)
Key Reasons For Testing
Crohn’s Disease Diagnosis: Identifies ASCA as a marker to help diagnose Crohn’s disease.
Differential Diagnosis: Distinguishes Crohn’s disease from conditions like ulcerative colitis or celiac disease.
Predictive Marker: Assesses disease severity and potential need for surgical intervention.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease. Gut.1998;42(6):788-791.
[2] Vermeire S, Peeters M, Vlietinck R, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and response to therapy. Gut. 2001;48(3):360-362.
[3] Joossens S, Reinisch W, Vermeire S, et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology. 2002;122(5):1242-1247.
[4] Reese GE, Constantinides VA, Simillis C, et al. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. American Journal of Gastroenterology.2006;101(10):2410-2422.
[5] Vasiliauskas EA, Kam LY, Karp LC, et al. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut. 2000;47(4):487-496.
[6] Dubinsky MC, Fleisher M, Seidman EG. Clinical utility of serodiagnostic testing in inflammatory bowel disease: how useful are biomarkers? American Journal of Gastroenterology. 2006;101(3):508-515.
[7] Targan SR, Landers CJ, Yang H, et al. Expression of anti-Saccharomyces cerevisiae antibody (ASCA) is associated with clinical features of Crohn's disease. Gastroenterology. 2005;128(4 Suppl 1).
[8] Lakatos PL, Altorjay I, Szamosi T, et al. Pancreatic autoantibodies are associated with penetrating, perianal disease behavior in Crohn's disease but not with NOD2/CARD15 mutations. American Journal of Gastroenterology.2007;102(2):333-340.
[9] Annese V, Andreoli A, Andriulli A, et al. Familial expression of anti-Saccharomyces cerevisiae antibody in Crohn's disease and ulcerative colitis. Gut. 2001;48(6):760-761.
[10] Stoll M, Corneliussen B, Costello CM, et al. Genetic variation at the IBD5 locus predicts ASCA expression and disease behavior in Crohn's disease. Gut. 2004;53(7):987-993.